This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Problems associated with sleep, whether sleep patterns or sleep disorders, are becoming more important due to the complications that can arise from these issues. Sleep apnea, especially, can influence long-term cardiac health and poor sleep quality could impact performance during the day, as well as an individual's quality of life. The NIH sleep research plan indicates there is a need to better understand sleep disorders, and for investigation into unobtrusive ways to monitor sleep that can accommodate the screening of large populations. To that end, the following hypotheses will be tested:1. The NAPS System can provide valid measurements of physiological parameters - heart rate and regularity, respiration rate and regularity, movement and body surface temperature - that when combined, are used in assessing sleep architecture, sleep patterns and sleep disorders like sleep apnea.2. The constraining nature of clinical (here GCRC sleep lab) polysomnography set-up, measurement equipment and environment may affect the subject's sleep. Therefore, there are differences in the frequency and timing of sleep apnea/arousal events measured by the NAPS system over a single night in the GCRC sleep lab and the nightly average of the same measurements performed over three-nights in the subject's home. 3. Using the NAPS system, we can measure sleep patterns, interruptions and efficiency at least as equally and as accurately as the accepted in-home standards of wrist actigraphy and a modified version of the Pittsburgh Sleep Quality Index (PSQI). Hence we can develop an objective, in-home sleep assessment tool that may exceed the capabilities of current subjective assessment tools (like the PSQI) even when combined with wrist actigraphy.By using accepted clinical (polysomnography) and in-home (actigraphy and subjective assessment tool) standards as benchmarks for testing the NAPS system, we intend to field-test and validate the efficacy of this system in both environments. This research builds on a previous study where we were able to develop algorithms to automatically analyze and score the NAPS data. As primary goals of this study, we will further validate these algorithms, the NAPS system, and efficacy of this objective tool for in-home sleep assessment and screening.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000847-34
Application #
7606716
Study Section
Special Emphasis Panel (ZRR1-CR-8 (01))
Project Start
2007-03-01
Project End
2008-02-29
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
34
Fiscal Year
2007
Total Cost
$10,691
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Campbell, Garland A; Patrie, James T; Gaylinn, Bruce D et al. (2018) Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study. Nephrol Dial Transplant 33:523-530
Malin, Steven K; Rynders, Corey A; Weltman, Judy Y et al. (2016) Endothelial function following glucose ingestion in adults with prediabetes: Role of exercise intensity. Obesity (Silver Spring) 24:1515-21
Rynders, Corey A; Weltman, Judy Y; Malin, Steven K et al. (2016) Comparing Simple Insulin Sensitivity Indices to the Oral Minimal Model Postexercise. Med Sci Sports Exerc 48:66-72
Nass, Ralf; Nikolayev, Alexander; Liu, Jianhua et al. (2015) The level of circulating octanoate does not predict ghrelin O-acyl transferase (GOAT)-mediated acylation of ghrelin during fasting. J Clin Endocrinol Metab 100:E110-3
Argo, Curtis K; Patrie, James T; Lackner, Carolin et al. (2015) Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. J Hepatol 62:190-7
Chyun, Deborah A; Wackers, Frans J Th; Inzucchi, Silvio E et al. (2015) Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE Open Med 3:2050312114568476
Hu, Yinin; Kim, Helen; Blackwell, Christopher M et al. (2015) Long-term outcomes of helper peptide vaccination for metastatic melanoma. Ann Surg 262:456-64; discussion 462-4
Marozkina, Nadzeya V; Wang, Xin-Qun; Stsiapura, Vitali et al. (2015) Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity. Eur Respir J 45:87-97
Nass, Ralf; Farhy, Leon S; Liu, Jianhua et al. (2014) Age-dependent decline in acyl-ghrelin concentrations and reduced association of acyl-ghrelin and growth hormone in healthy older adults. J Clin Endocrinol Metab 99:602-8
Hu, Yinin; Petroni, Gina R; Olson, Walter C et al. (2014) Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine. Cancer Immunol Immunother 63:779-86

Showing the most recent 10 out of 674 publications